- Home
- BHAT vs VRAX Comparison
BHAT vs VRAX Comparison
Compare BHAT & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHAT | VRAX |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.1M | 2.9M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BHAT | VRAX |
|---|---|---|
| Price | $1.19 | $0.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 101.8K | ★ 908.5K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $18,972,415.00 | $2,986.00 |
| Revenue This Year | N/A | $217,274.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.07 | $0.31 |
| 52 Week High | $15.80 | $3.20 |
Technical Indicators
Market Signals| Indicator | BHAT | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 37.59 | 44.43 |
| Support Level | $1.11 | $0.31 |
| Resistance Level | $1.28 | $0.51 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 14.29 | 35.19 |
Price Performance
Historical ComparisonAbout BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).